R

    Reviva Pharmaceuticals Holdings Inc. (RVPH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.52
    +0.01 (+2.77%)

    Market Cap: $6.80M

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(14/24)
    Avg Surprise
    -319.31%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.18
    Range$-0.18 - $-0.18
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.23-27.8%
    60d ago$-0.36-100.0%
    30d ago$-0.36-100.0%
    7d ago$-0.36-100.0%
    Current$-0.18
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Dec 31, 2026
    EPS Consensus$0.03
    Range$0.03 - $0.03
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.03---
    Sep 26EST
    		-$-0.18---
    Jun 26
    		$-0.19N/A+53.66%Beat+92.1%
    Mar 26
    		$-0.46$-0.29-58.62%Miss+82.3%
    Dec 25
    		$-5.19$-0.07-7179.10%Miss-476.7%
    Sep 25
    		$-1.20$-1.94+38.14%Beat+76.0%
    Jun 25
    		$-2.40$-2.20-9.09%Miss+53.8%
    Mar 25
    		$-2.60$-3.65+28.77%Beat+48.0%
    Dec 24
    		$-0.90$-0.23-300.00%Miss-157.1%
    Sep 24
    		$-5.00$-5.00+0.00%Beat+43.2%
    Jun 24
    		$-5.20$-6.20+16.13%Beat+52.7%
    Mar 24
    		$-5.00$-7.53+33.60%Beat+16.7%
    Dec 23
    		$-0.35$-0.35+0.00%Beat+7.9%
    Sep 23
    		$-8.80$-7.75-13.55%Miss-144.4%
    Jun 23
    		$-11.00$-5.00-120.00%Miss-89.7%
    Mar 23
    		$-6.00$-5.80-3.45%Miss+25.0%
    Dec 22
    		$-0.38$-0.22-72.73%Miss-72.7%
    Sep 22
    		$-3.60$-5.20+30.77%Beat-50.0%
    Jun 22
    		$-5.80$-7.00+17.14%Beat-141.7%
    Mar 22
    		$-8.00$-5.00-60.00%Miss-7900.0%
    Dec 21
    		$-0.22$-0.25+12.00%Beat+93.3%
    Sep 21
    		$-2.40$-4.60+47.83%Beat-5900.0%
    Jun 21
    		$-2.40$-4.80+50.00%Beat-3900.0%
    Mar 21
    		$-0.10$-0.10+0.00%Beat-100.0%
    Dec 20
    		$-3.30$-1.20-175.00%Miss-6700.0%
    Sep 20
    		$-0.04$-0.04+0.00%Beat-136.4%
    Jun 20
    		$-0.06N/AN/ABeat-146.2%
    Mar 20
    		$-0.05N/AN/ABeat-101.9%
    Dec 19
    		$0.05N/AN/ABeat-93.3%
    Sep 19
    		$0.11N/AN/ABeat-94.6%
    Jun 19
    		$0.13N/AN/ABeat-
    Mar 19
    		$2.60N/AN/ABeat-
    Dec 18
    		$0.74N/AN/ABeat-
    Sep 18
    		$2.03N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.07EV/EBITDA-6.00x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-176.60%ROIC-87.76%
    Financial Health
    Debt/Equity0.01xInterest Coverage-2049.61x
    Current Ratio3.56xQuick Ratio3.56x
    Trading Statistics
    Beta0.49Avg Volume33.04K
    52-Week High$17.2052-Week Low$0.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.49
    SMA 20$0.48
    SMA 50$0.53
    SMA 200$3.57
    EMA 10$0.50
    EMA 20$0.49
    EMA 50$0.57
    EMA 200$3.63

    MACD

    Line: -0.00Signal: -0.01Hist: 0.01

    ADX

    ADX: 18.5+DI: 13.4-DI: 7.8

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down8.0
    PSAR$0.41

    Bollinger Bands

    Upper Band$0.55
    Lower Band$0.41
    %B Position2785%(Upper)
    Band Width0.80

    RSI (14-Day)

    Neutral
    53.7

    Momentum Oscillators

    Stoch %K70.9
    Stoch %D66.4
    Williams %R-25.8
    ROC (10d)1.7%
    Momentum0.01
    CCI (20d)115.5
    MFI (14d)75.7

    Volatility Measures

    ATR (14d)$0.07(13.4%)
    StdDev (20d)0.03
    Hist Vol144.0%(High)

    Volume Flow

    VWAP$0.51
    OBV-32.2M
    AD Line383.9B
    CMF (20d)0.109

    Volume Metrics

    Avg Vol (20d)31.4K
    Vol Ratio0.4x(Low)
    VWMA (20d)$0.48

    Pivot Points

    R3$0.57
    R2$0.54
    R1$0.52
    Pivot Point$0.50
    S1$0.48
    S2$0.45
    S3$0.43

    Advanced Oscillators

    TSI-0.87
    Ultimate Osc51.5
    KST-18.13

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Operating Expenses$2.62M$3.27M$3.56M$4.03M$6.07M$6.54M$6.28M$8.46M$8.13M$7.92M$9.62M$11.56M
    R&D$1.39M$1.44M$1.74M$2.13M$3.72M$4.11M$4.68M$6.86M$5.58M$5.78M$8.11M$9.57M
    SG&A$1.22M$1.84M$1.82M$1.90M$2.35M$2.42M$1.60M$1.60M$2.55M$2.14M$1.51M$1.99M
    Operating Income$-2,617,543$-3,271,952$-3,559,041$-4,029,841$-6,072,982$-6,538,167$-6,284,606$-8,462,534$-8,129,643$-7,922,106$-9,619,346$-11,563,954
    Interest Income$176,319$89,354$143,309$59,103$22,847$86,111$47,413$53,248$87,610$173,098$56,559$91,763
    Interest Expense$2,935$6,653$-5,620$2,605$4,797$11,620$4,711$5,146$5,153$3,487$7,410$5,901
    Income Before Tax$-2,445,199$-3,192,641$-3,364,797$-4,007,933$-6,045,656$-6,427,627$-6,254,744$-8,365,798$-7,852,534$-7,426,212$-9,359,846$-11,333,819
    Income Tax Expense$2,632$3,346$2,882$2,840$7,954$5,213$4,733$0$7,385$7,396$-4,582$12,117
    Net Income$-2,447,831$-3,195,987$-3,367,679$-4,010,773$-6,053,610$-6,432,840$-6,259,477$-8,365,798$-7,859,919$-7,433,608$-9,355,264$-11,345,936
    EBITDA$-2,618,583$-3,275,342$-3,513,726$-4,064,431$-6,063,706$-6,502,118$-6,297,446$-8,413,900$-7,934,991$-7,595,823$-9,408,995$-11,419,681
    EBIT$-2,618,583$-3,275,342$-3,513,726$-4,064,431$-6,063,706$-6,502,118$-6,297,446$-8,413,900$-7,934,991$-7,595,823$-9,408,995$-11,419,681
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RVPH

    News

    Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake

    Millennium entities, including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, have disclosed a beneficial ownership of 1,072,690 shares, representing an 8.2% stake in Reviva Pharmaceuticals Holdings, Inc. This information was reported in an Amendment No. 1 to Schedule 13G, indicating shared voting and dispositive power over these shares. The filing includes a Joint Filing Agreement dated July 31, 2026.

    Stock Titan•8/3/26•
    Neutral

    UBS Group (RVPH) exits Reviva Pharmaceuticals stake in updated report

    UBS Group AG, along with its subsidiaries, has reported that it no longer beneficially owns any shares of Reviva Pharmaceuticals Holdings, Inc. common stock as of June 30, 2026. The filing indicates that UBS Group now holds 0% of the class, with no voting or dispositive power, confirming it holds 5 percent or less of the class. This disclosure was made in an updated SCHEDULE 13G/A filing.

    Stock Titan•8/1/26•
    Neutral

    REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. Market Sentiment

    This article provides an overview of market sentiment for Reviva Pharmaceuticals Holdings, Inc. (RVPH), including analyst consensus, short interest, and recent analyst actions. The consensus among 12 analysts is a "Buy" rating with an average price target of $10, suggesting a significant upside. The short interest is noted as 3.9% and declining, which is considered bullish.

    Benzinga España•7/27/26•
    Somewhat-Bullish

    Operating margin % of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH

    The article provides the operating margin percentage for Reviva Pharmaceuticals Holdings, Inc. (OTC: RVPH), as seen on TradingView. It highlights that the market is currently closed with no trades. The content primarily focuses on presenting the financial metric for the specified company.

    TradingView•7/18/26•
    Neutral

    Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) — Files Form 25 to remove Common Stock from Nasdaq listing

    Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) has filed a Form 25 to remove its Common Stock from Nasdaq listing. This procedural filing indicates that Nasdaq Stock Market LLC and the issuer have complied with the necessary rules for voluntary withdrawal, as certified by Nasdaq. The delisting means Reviva's common stock will no longer be traded on Nasdaq, potentially impacting its visibility and trading liquidity.

    Stock Titan•7/10/26•
    Somewhat-Bearish

    Frequently Asked Questions About RVPH

    Does RVPH pay dividends?
    Reviva Pharmaceuticals Holdings Inc. (RVPH) does not currently pay a regular dividend.
    What is RVPH's market cap?
    Reviva Pharmaceuticals Holdings Inc. (RVPH) has a market capitalization of $6.80M with a current stock price of $0.52.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In